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Purpose: To investigate whether myopia development is associated with changes of scleral DNA methylation in cytosine-
phosphate-guanine (CpG) sites in the collagen 1A1 (COL1A1) promoter and messenger RNA (mRNA) levels following
murine form deprivation myopia.
Methods: Fifty-seven C57BL/6 mice (postnatal day 23) were randomly assigned to four groups: (1) monocular form
deprivation (MD) in which a diffuser lens was placed over one eye for 28 days; (2) normal controls without MD; (3) MD
recovery in which the diffuser lens was removed for seven days; and (4) MD recovery normal controls. The DNA
methylation pattern in COL1A1 promoter and exon 1 was determined by bisulfite DNA sequencing, and the COL1A1
mRNA level in sclera was determined by quantitative PCR.
Results: MD was found to induce myopia in the treated eyes. Six CpG sites in the promoter and exon 1 region of
COL1A1 were methylated with significantly higher frequency in the treated eyes than normal control eyes (p<0.05), with
CpG island methylation in MD-contralateral eyes being intermediate. Consistent with the CpG methylation, scleral
COL1A1 mRNA was reduced by 57% in the MD-treated eyes compared to normal controls (p<0.05). After seven days of
MD recovery, CpG methylation was significantly reduced (p=0.01). The methylation patterns returned to near normal
level in five CpG sites, but the sixth was hypomethylated compared to normal controls.
Conclusions: In parallel with the development of myopia and the reduced COL1A1 mRNA, the frequency of methylation
in CpG sites of the COL1A1 promoter/exon 1 increased during MD and returned to near normal during recovery. Thus,
hypermethylation of CpG sites in the promoter/exon 1 of COL1A1 may underlie reduced collagen synthesis at the
transcriptional level in myopic scleras.
Myopia is the most common eye disorder in the world,
and its prevalence is estimated to be 33% in some Western
countries [1,2]. It is especially high, 65 to 88%, in students
from  Asian  regions  and  countries,  including  Hong  Kong
[3-5],  Taiwan  [6],  and  Singapore  [7].  However,  the
mechanism by which myopia develops has not been fully
clarified.
Several lines of experimental evidence strongly suggest
that the pathological changes in the sclera of myopic eyes can
be  associated  with  reduced  synthesis  and  increased
degradation of type I collagen [8]. Each monomeric unit of
type I collagen protein is a heterotrimer composed of two type
I alpha 1 (COL1A1) and one type I alpha 2 (COL1A2) chains.
The  gene  for  the  major  component  of  type  I  collagen
(COL1A1)  [9],  is  located  on  human  chromosome  17
(17q21.33), within the high myopia candidate locus MYP5
Correspondence  to:  Jia  Qu,  School  of  Ophthalmology  and
Optometry  and  Eye  Hospital,  Wenzhou  Medical  College,  270
Xueyuan Road, Wenzhou, Zhejiang 325003, P. R. China; Plone:
+86-577-88824116; FAX: +86-577-88824115; email: jqu@wz.zj.cn
(17q21–22)  [10-12].  Several  studies  have  focused  on  its
expression  during  myopia  [13-15].  In  the  tree  shrew,
expression of collagen type I messenger RNA (mRNA) is
reduced in the sclera of myopic eyes and increases to normal
levels  during  myopia  recovery  [13-15].  However  the
mechanism of COL1A1 modulation in myopia still remains
unclear.
One  mechanism  of  gene  expression  regulation  is
mediated  by  DNA  methylation  of  cytosine-phosphate-
guanine  (CpG)  sites  within  promoters.  This  process  can
generally lead to gene silencing, a feature found in several
human cancers in which expression of tumor suppressor genes
is inhibited [16,17]. In contrast, the hypomethylation of CpG
sites  is  associated  with  the  overexpression  of  oncogenes
within cancer cells [18]. DNA methylation is controlled by an
array of DNA methylation transferases and demethylation
enzymes.  The  promoter  region  of  COL1A1  contains  CpG
islands [19], and methylation in this region, as well as in exon
1, depresses COL1A1 gene expression in cultured 3T3 mouse
embryo tissue fibroblasts and F9 embryonal carcinoma cells
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1312[19]. Suppression of COL1A1 gene expression is associated
with increased DNA methylation after the transformation of
normal human lung fibroblasts by Simian vacuolating virus
40 (SV40) [20]. However, there have been no reports on
changes in COL1A1 methylation or that of other genes in the
development  of  myopia.  In  this  study,  we  used  the
experimental  mouse  model  of  myopia  to  evaluate  the
methylation status of CpG sites in the promoter and exon 1
region of COL1A1 in the scleras of myopic and control eyes.
We also correlated the DNA methylation pattern with the
expression of COL1A1 mRNA during the onset of myopia.
METHODS
Development of form-deprivation myopia in mice: All animals
were obtained from the animal breeding unit at Wenzhou
Medical College and raised in standard mouse cages with a
12 h:12 h light-dark cycle. The study was approved by the
Animal  Care  and  Ethics  Committee  at  Wenzhou  Medical
College (Wenzhou, China). The experiments were conducted
in  accordance  with  the  ARVO  Statement  for  the  Use  of
Animals in Ophthalmic and Vision Research.
Four groups of 23-day-old C57BL/6 mice were included
in the study: (1) A monocular deprivation (MD) group (n=28)
was form deprived for four weeks, from 23 to 51 days of age.
This was achieved by the placement of a light-diffusing lens
over a randomly chosen eye as Schaeffel et al. [21] described.
(2)  An  age-matched  normal  control  group  (n=14)  was
maintained free of form deprivation for the same four-week
period.  (3)  A  separate  MD  group  (n=10)  was  allowed  to
recover by removal of the diffuser lens for seven days (days
51–58) after the four weeks of form deprivation. (4) Finally,
another age-matched normal group (n=5) was established for
the MD mice that were allowed to recover for seven days.
These mice were similar to the first normal control group in
that neither eye was form deprived.
Measurements for refraction and ocular dimensions at the
beginning and end of the treatment periods were taken as
described below.
Refraction—The refractive state was measured in a dark
room with an eccentric infrared photorefractor as previously
described,  which  was  calibrated  according  to  a  published
procedure [22,23]. Briefly, the mouse was gently restrained
by holding its tail and positioning it on a small stage in front
of  the  photoretinoscope.  On-axis  measurements  were
recorded when the Purkinje image was present in the center
of the pupil [21]. The data were then recorded using software
designed by Schaeffel et al. [21]. Measurements were repeated
at least three times for each eye.
Ocular  dimensions—Ocular  dimensions,  including
anterior  chamber  depth,  lens  thickness,  vitreous  chamber
depth, and axial length were measured by real-time optical
coherence tomography using a custom-built optical coherence
tomography instrument [24]. Anterior chamber depth was
defined as the distance from the posterior surface of the cornea
to the anterior surface of the lens. Axial length was defined as
the distance between the anterior surface of the cornea and the
vitreous-retinal interface. Each eye was scanned three times.
Corneal curvature measurement—Corneal curvature
was measured with a keratometer (Topcon OM-4; Topcon
Corp., Tokyo, Japan) that was modified by mounting a +20.0-
diopter (D) aspherical lens as previously described [22,23].
Each eye was measured three times to obtain a mean value.
DNA  isolation:  Mice  were  sacrificed  by  an  overdose  of
pentobarbitone  sodium.  Immediately  after  removal  of  the
diffuser, the eyes were enucleated and dissected to obtain the
sclera  free  of  other  tissues.  The  separated  sclera  was
immediately stored in liquid nitrogen at −80 °C before total
DNA was isolated. Due to the small amount of DNA in the
scleral tissue, scleras from pairs of eyes were pooled to obtain
sufficient DNA for analysis. For the form-deprived eyes, two
scleras  from  the  MD-treated  (MD-T)  eyes  were  pooled.
Scleras from the untreated contralateral eyes (MD-C) of the
MD-T mice were also pooled. Scleras from treated eyes that
were allowed to recover for seven days were pooled as the
MD-treated-recovery  group  (MD-R).  The  contralateral
control eyes of that group were pooled as the MD-treated-
recovery  control  (MD-RC)  group.  The  final  two  groups
consisted of scleras from normal control mice at 51 and 58
days of age (NC51 and NC58, respectively). For these control
animals, the two eyes were treated in the same way, i.e., they
had no treatment; therefore, the scleras (left and right) were
pooled  from  the  same  animal  rather  than  from  separate
animals.
Total DNA was extracted with proteinase K treatment
and  a  phenol-extraction  procedure  according  to  standard
methods [25]. DNA concentration and purity were determined
by spectrophotometry at 260 nm and 280 nm. The A260/A280
absorbance  ratio  was  consistent  at  approximately  1.8.  An
average of 1.2 μg of total DNA was obtained from every
scleral pool.
Bisulfite modification of DNA: Bisulfite modification of DNA
was performed using the CpGenome DNA Modification Kit
(Millipore,  Billerica,  MA)  following  the  manufacturer’s
directions: 1 μg DNA was denatured in 0.3 M NaOH for 10
min at 37 °C in a final volume of 107 μl. It was then mixed
with 550 μl of 3.6 M sodium bisulfite and incubated for 16 h
at 50 °C.
After alkaline desulfonation and final desalting, single-
stranded uracil-containing reaction products were eluted in
30 μl of buffer composed of 10 mM Tris-HCl and 1 mM
EDTA  at  pH  8.0.  Sodium  bisulfite  was  used  to  convert
unmethylated  cytosine  into  uracil.  Following  PCR
amplification, all unmethylated cytosines within a sequence
were replaced with thymine (Table 1). Methylated cytosines
remained as cytosine following PCR amplification.
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DNA:  Bisulfite  sequencing  PCR  was  based  on  the
indiscriminant amplification of a section of methylated or
unmethylated DNA containing CpG sites within the amplicon
but not the primer sequence (Table 1). It requires only one set
of  primers  to  amplify  both  methylated  and  unmethylated
DNA,  which  can  then  be  distinguished  by  subsequent
sequencing. Using the Methyl Primer Express v1.0 (Applied
Biosystems, Foster City, CA), PCR primers were designed
according  to  the  published  DNA  sequences  of  COL1A1:
Forward, 5′-GTT TAT GTA GAT TTG GGG GGT A-3′;
reverse, 5′-AAC TCC CCA AAA TTT AAA ACT T-3. The
primers  were  specially  tested  using  methBLAST.  The
amplified 447 base pair (bp) fragment was between −247 and
+200 in the COL1A1 promoter and exon 1 region. It contained
19 CpG dinucleotide sites.
PCR  amplification  of  100  ng  bisulfate-treated  DNA
template  was  performed  in  a  reaction  mixture  containing
0.5 μl 20 pM forward and reverse primers, 4 μl of 25 mM
Mg2+, 10 μl of 5× buffer, 1 μl of 2.50 mM deoxynucleotide
triphosphates,  0.25  μl  of  Go  Taq  Hot  Start  Polymerase
(Promega, Madison, WI), and 34.25 μl distilled water for a
total volume of 50 µl. Amplification conditions included an
initial denaturation at 95 °C for 10 min, followed by 40 cycles
at 95 °C for 30 s, 55.7 °C for 30 s, and 72 °C for 1 min. The
final extension at 72 °C lasted 10 min. The purified PCR
products were cloned into plasmid vectors by means of a
TOPO  TA  Cloning  Kit  (Invitrogen,  Carlsbad,  CA),  and
around  30  positive  clones  were  chosen  for  sequencing.
Successful ligations were detected by blue-white selection,
and positive clones were selected for PCR using the same
amplification conditions described above. Since there were 19
CpG sites in the 5′ promoter region of COL1A1, we analyzed
19 sites × 5 samples per group=95 CpG sites per experimental
group. The percentage of methylated CpGs was calculated by
the number of methylated CpGs divided by the total number
of CpGs analyzed.
Many  transcription  factors  may  bind  to  the  DNA
sequence of the amplified fragment, the online software of P-
Match 1.0 was used to predict transcription factor binding
sites.
RNA isolation: Scleras were isolated and pooled as described
above. To avoid mRNA degradation, the scleras were placed
immediately  into  room-temperature  RNA  Later  (Ambion,
Foster City, CA). The RNA Later was then removed after
remaining at 4 °C overnight, and the scleras were stored at
−80 °C for later use.
Total  RNA  was  extracted  using  the  RNeasy  Fibrous
Tissue Mini Kit (Qiagen, GmbH, Hilden, Germany) at room
temperature. Tissue samples were pooled as described above
(pooled MD-T eyes, n=9; pooled MD-C eyes, n=9; pooled
normal control eyes, n=9). RNA concentration and purity
were determined by spectrophotometry at 260 nm and 280 nm.
The A260/A280 absorbance ratio was consistently about 1.9,
indicating high purity of RNA. An average of 1 μg of total
RNA was obtained from each of the pooled scleras. To remove
contaminating genomic DNA, 1 μg of total RNA was treated
with 1 U RNase free DNase I (Promega, Madison, WI) at 37
°C  for  30  min  and  then  heated  with  1  μl  stop  solution
(Promega) at 65 °C for 10 min.
Quantitative PCR: Single-strand cDNA was synthesized from
400  ng  RNA  in  20  µl  of  reaction  volume  using  the
preamplification  system  M-MLV  Reverse  Transcriptase
(Promega). After reverse transcription, the COL1A1 mRNA
level was measured by real-time reverse transcriptase (RT)-
PCR analysis (Power SYBR Green PCR Master Mix; Applied
Biosystems)  [26].  Primers  were  designed  using  Primer
Express 3.0 software (Applied Biosystems) and amplified 100
bp to 150 bp cDNA fragments (Table 2). The mouse 18S
rRNA  gene  was  used  as  an  internal  control  based  on  its
constant level of expression among the different groups [27].
Quantitative PCR was performed with 2.5 nM primers
(ABI 7500; Applied Biosystems) and 1 μl of cDNA in a
15 μl reaction for 40 cycles under the following conditions:
TABLE 1. BISULFITE SEQUENCE PCR MEASUREMENT MECHANISM.
Sequence Unmethylated DNA Methylated DNA
Initial sequence AACTGACGTACTACG AACTGACmGTACTACmG
Converted sequence AAUTGAUGTAUTAUG AAUTGACGTAUTACG
PCR product sequence AATTGATGTATTATG AATTGACGTATTACG
TABLE 2. QUANTITATIVE PCR GENE PRIMER PAIRS.
Gene name Forward Primers (5′-3′) Reverse Primers (5′-3′) Length
(bp)
COL1A1 GAGAGCGAGGCCTTCCCGGA GGGAGCCAGCGGGACCTTGT 131
18S rRNA CGGACACGGACAGGATTGAC TGCCAGAGTCTCGTTCGTTATC 124
          COL1A1: collagen type Iα1; 18S rRNA was the housekeeping gene.
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131450 °C for 2 min and 95 °C for 10 min, followed by 40 cycles
of amplification at 95 °C for 15 s and 60 °C for 60 s. All
experiments were performed in duplicate.
The expression level of COL1A1 mRNA was normalized
to  that  of   an  internal   control  18S  rRNA  [27].   We  used
the  relative  expression  level  to  indicate  the  fold  change
between different groups of eyes by using the equation of
2−ΔΔCt, where:
ΔΔCt =  (CTCOL1A1- CT18S rRNA) MD-T/MD-C/NC51-
(CTCOL1A1- CT18S rRNA) NC51
Statistical analysis: Statistical analyses were performed using
the Statistical Procedures for the Social Sciences (SPSS 13.0,
SPSS, Chicago, IL). Descriptive statistics were calculated as
means  and  standard  error.  Statistical  differences  between
groups  were  calculated  by  independent  sample  t  test.
Differences of biometric parameter between the MD-T eyes
and the MD-C eyes in the same group were calculated by
paired sample t test and differences of biologic parameter
between the MD-T eyes and the MD-C eyes in the same group
were calculated by independent sample t test. A p value <0.05
was considered to be statistically significant.
RESULTS
Confirmation that form deprivation induces myopia: There
were no significant differences in refraction or axial length
among all groups before the experiment. Additionally, there
were no significant differences in refraction or axial length
between the two eyes of the same animal (p=0.24 and 0.62,
respectively, paired sample t test). After 28 days of form
deprivation, refractions for the MD-T eyes and MD-C eyes
were −2.81±0.63 D and 3.35±0.70 D, respectively (paired t
test, p<0.001, Figure 1A). Refraction in the MD-T eyes was
also  significantly  different  from  NC51  eyes,  5.39±0.63  D
(independent sample t test, p<0.001, Figure 1A). The axial
lengths  for  the  MD-T  eyes  and  MD-C  eyes  were
2.97±0.05 mm and 2.92±0.05 mm, respectively (paired t test,
p<0.001,  Figure  1B);  however,  there  were  no  significant
differences in the axial lengths between MD-T eyes and MD-
C eyes (2.94±0.08 mm). The vitreous chamber depth for the
MD-T eyes, MD-C eyes, and NC51 eyes were 0.69±0.01 mm,
0.66±0.01 mm, and 0.65±0.01 mm, respectively. The MD-T
vitreous depth was significantly greater than in the MD-C
(paired t test, p<0.01, Figure 1C) and NC51 eyes (independent
sample t test, p<0.05, Figure 1C). The corneal curvature,
anterior  chamber  depth,  and  lens  thickness  were  not
significantly different when MD-T eyes were compared to
MD-C and NC51 eyes. Furthermore, there were no significant
differences  in  refraction,  axial  components,  or  corneal
curvature between MD-C eyes and NC51 eyes.
DNA methylation of the COL1A1 promoter in the monocular
form deprivation (MD) groups: DNA methylation profiles for
MD-T, MD-C, and NC51 eyes were determined after four
weeks of monocular form deprivation (Table 3). In MD-C and
NC51 eyes, most of the CpG sites exhibited very low levels of
DNA methylation, whereas in MD-T eyes, the levels were
elevated at most of the sites (Figure 2A). The amount of
methylation in MD-T eyes was higher than in MD-C eyes
(Figure 3). The methylation percentages of six CpG sites (1,
3, 9, 14, 18, and 19) in MD-T eyes were significantly increased
compared to the NC51 eyes (Figure 4). In MD-C eyes, the CpG
sites were methylated at a level intermediate between the MD-
T and NC51 eyes (Figure 3). The methylation percentages of
four CpG sites (3, 8, 14, and 18) in MD-C eyes tended to
increase compared to the NC51 eyes, although only site 14 was
significantly increased (Figure 4).
DNA methylation of the COL1A1 promoter in the monocular
form deprivation (MD) recovery groups: A similar analysis
was performed for the MD-R eyes and MD-RC eyes. For each
sample, about 30 to 34 DNA clones were analyzed. DNA
methylation profiles for MD-R, MD-RC, and NC58 eyes were
determined after seven days of recovery following four weeks
of monocular form deprivation (Table 4 and Figure 2B). In
MD-R eyes, the levels of DNA methylation were lower than
those seen in MD-T eyes (p<0.01, Figure 3). However, DNA
methylation in MD-RC and NC58 eyes was not significantly
different from that of the MD recovery eyes (Figure 3).
In the MD-R eyes, the methylation percentages of the six
CpG sites that were previously elevated (1, 3, 9, 14, 18, and
19) were similar to those of the MD-RC and NC58 eyes (Figure
5). Thus, the recovery from myopia was associated with a loss
of  DNA  methylation  at  the  CpG  sites.  The  methylation
percentage of CpG site 11 in the MD-R eyes was reduced
significantly compared to the NC58 eyes (Figure 5).
Downregulation  of  scleral  COL1A1  mRNA  level  during
myopia: Scleral COL1A1 mRNA levels were lower by 57%
in the MD-T eyes than the MD-C eyes (p<0.05, Figure 6).
Moreover, the COL1A1 mRNA levels were 42% lower in the
MD-T eyes compared to the normal control eyes (p<0.05,
Figure 6).
DISCUSSION
Because of the large number of gene knockout and transgenic
mouse models and the molecular tools available for studying
them, murine models of induced myopia have advantages over
other  traditional  species  in  some  respects.  Thus,  mouse
models have been increasingly used to study the molecular
basis of myopia [21-23,28,29]. In our study, the MD-T eyes
were significantly more myopic compared to the MD-C eyes
and the normal control eyes (NC51). Similarly, the vitreous
chamber depth was significantly increased at the MD-T eyes
compared to the MD-C and NC51 eyes, results which were not
different from other studies [29-32]. The axial length in MD-
T eyes was significantly greater than in MD-C eyes, but not
significantly greater than in NC51 eyes. There is a possible
explanation for this apparent difference between the MD-C
and NC51 eyes. There were great individual differences in
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1315Figure 1. Ocular refraction parameters of mice for quantitative PCR in monocular deprived and control eyes. A: Eyes treated by monocular
deprivation (MD-T, n=18) for 28 days were significantly more myopic than were contralateral control (MD-C, n=18) and age-matched normal
control (NC51, n=9) eyes. B: The MD-T eyes also exhibited significantly greater axial length than did the MD-C eyes, but not the NC51 eyes.
C: Differences in the vitreous chamber depths among the treated eyes and contralateral control eyes compared to age-matched normal control
eyes (NC51) were significant, *, p<0.05, **, p<0.01. All error bars in figures show the standard error (SE).
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1317axial  length  among  the  mice  in  each  of  the  groups.  This
resulted in the detection of axial length differences between
only the MD-T eyes and MD-C eyes of the same animals.
DNA methylation is known to inhibit gene expression in
human cancer [16,17], murine cultured 3T3 cells, and F9
embryonal carcinoma cells [19]. The hypomethylation of CpG
sites is also associated with overexpression of certain genes
in cancer cells [18]. It is now known that the expression of
COL1A1 is controlled by many factors, including a change of
DNA methylation status [33,34]. For instance, transformation
of  normal  human  lung  fibroblasts  by  SV40,  which  is
associated  with  increased  DNA  methylation,  suppresses
COL1A1 gene expression [20].
Compared to the normal control eyes (NC51), the total
methylation level in the CpG promoter sites for COL1A1
increased significantly after four weeks of monocular form
deprivation. Seven days after returning to normal vision, this
level of methylation returned to the same levels as in the
control eyes (NC58). The total methylation level in the MD-T
eyes was significantly greater than in the NC51 eyes, but not
the MD-C eyes, because the methylation level of some CpG
sites of COL1A1 in MD-C eyes also changed during myopia
Figure 2. Proportion of sites that were
methylated  in  the  proximal  promoter
and  a  portion  of  exon  1.  A:  Form-
deprived,  contralateral  control,  and
normal control eyes after four weeks of
monocular form deprivation. B: Form-
deprived,  contralateral  control,  and
normal control eyes after one week of
recovery  following  four  weeks  of
monocular deprivation (MD). Detailed
maps  of  cytosine-phosphate-guanine
(CpG) sites in the proximal promoter
and first exon are shown. The beads in
the horizontal lines illustrate the CpG
sites, and the color of each indicates the
corresponding  degree  of  methylation:
gray, 0–0.1; blue, 0.1–0.2; green, 0.2–
0.3,  red,  >0.3.  MD-T:  monocular
deprivation-treated  eyes,  MD-C:
contralateral  control  eyes,  NC:  age-
matched normal control eyes, Numbers:
sample IDs.
Figure 3. Total DNA methylation in the monocular deprivation, monocular deprivation recovery, and control groups. Methylation of the
cytosine-phosphate-guanine (CpG) sites in the monocular deprivation–treated (MD-T) eyes was significantly greater than in normal control
and recovery eyes. MD-C: MD contralateral control eyes, NC51: age-matched normal control eyes; MD-R: after seven days of recovery
following four weeks of monocular deprivation, MD-RC: contralateral control eyes after recovery period, NC58: age-matched normal control
eyes for MD recovery, *, p<0.05.
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1318induction. Indeed, the methylation of sites 3, 8, 14, and 18 of
COL1A1 in the MD-C eyes tended to increase compared to
the  normal  control  eyes  (NC51).  This  shows  that  form
deprivation myopia in mice may also affect methylation of
COL1A1 in MD-C eyes, resulting in the absence of significant
differences in total methylation between the MD-T and MD-
C eyes.
Notably, methylation changes among MD-T, MD-C, and
NC51 eyes were consistent with refraction changes of myopic
eyes. During the period of form deprivation, the MD-C eyes
also showed a myopic shift compared to the normal control
eyes (NC51), albeit not significantly less than in the MD-T
eyes. Barathi et al. [29] also found this phenomenon in form
deprivation myopia in mice. The standard error of COL1A1
gene expression in MD-C eyes was clearly larger than in the
normal control eyes (NC51), indicating that some changes in
gene expression may have occurred. These results suggest that
in mice, unilateral form deprivation induces yoking effects in
contralateral MD-C eyes. This phenomenon has also been
observed in other animal models of myopia, such as the guinea
pig [35], tree shrew [15,36], and rhesus monkey [37].
CpG methylation site number 9 is within the binding site
of  transcription  factor  Adf-1,  and  CpG  methylation  site
number 14 is within the binding site for transcription factor
Sp1  (Figure  7).  In  Drosophila,  Adf-1  activates  the
transcription of many genes [38-40]. In normal human dermal
fibroblasts, Sp1 can activate the transcription of COL1A1
[41] During MD, methylation of the 9th and 14th CpG sites
may suppress COL1A1 gene expression by altering Adf-1 and
Sp1  binding.  After  MD  recovery,  those  locations  are
demethylated, and allow the binding of Adf-1 and Sp1. The
other four CpG sites, 1, 3, 18, and 19, which also became
methylated  during  MD  and  were  demethylated  during
recovery, are not located in transcription factor binding sites.
The functions of these CpG sites are not currently known. The
methylation of the CpG sites may have affected the structure
of  chromatin  [42-44]  or  the  binding  of  methyl-C-binding
proteins  [19]  in  the  treated  eyes  of  the  MD  group.
Interestingly, the 11th CpG site, which underwent significant
methylation  and  demethylation  during  treatment  and
recovery,  is  located  near  the  transcription  start  site  of
COL1A1. The loss of CpG methylation at this site in the MD
recovery eyes may promote the transcription of COL1A1,
which suggests renewed transcription of COL1A1 under these
conditions.
Because of the small amount of DNA and mRNA present
in the sclera, we used a pooling strategy for biologic analysis.
For normal control animals, both eyes from each animal were
pooled. For the MD-T group, the eyes from two animals were
pooled. Thus, the normal control tissue samples were more
homogenous  than  were  the  MD-T  samples.  This  sample
pooling and preparation method may have exaggerated the
apparent  statistical  differences  between  these  two  groups.
However, we also included the pooled MD-C eyes, which
were the untreated contralateral controls to the MD-T eyes.
Because these two groups were from the same animals, this
Figure 4. Methylation percentages of cytosine-phosphate-guanine (CpG) sites in the collagen type Iα1 promoter region in scleras of monocular
deprivation and control eyes after four weeks of monocular deprivation. Numbers in parentheses on the x-axis are the locations of the cytosine-
phosphate-guanine (CpG) sites. Methylation percentages at sites 1, 3, 9, 14, 18, and 19 were significantly greater in monocular deprivation–
treated (MD-T) eyes than age-matched normal control (NC51) eyes. MD-T: monocular deprivation-treated eyes, MD-C: contralateral control
eyes. *, p<0.05, **, p<0.01.
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1320comparison  (MD-T  eye  versus  MD-C  eye)  would  fully
address  any  possible  exaggerated  statistical  differences
between the MD-T and nontreated control eyes.
The COL1A1 gene is speculated to be a susceptibility
gene for high myopia, as it is located in MYP5 (17q21–22) of
high myopia candidate locus and is downregulated during
myopia in animal models [15-17]. However, until now, there
has  been  no  consensus  with  regard  to  its  role  in  the
development  of  myopia.  One  report  links  COL1A1
polymorphisms with high myopia in Japanese subjects [11],
but  others  do  not  confirm  this  [12,45-47].  Therefore,  the
association between COL1A1 and human high myopia may
not be completely attributed to the DNA sequences. Rather,
epigenetic factors such as DNA methylation should also be
considered.  It  is  widely  considered  that  the  interplay  of
heredity and environmental factors is important in low and
Figure 5. Methylation percentages of cytosine-phosphate-guanine (CpG) sites in the collagen type Iα1 promoter region in scleras of monocular
deprivation and control eyes after four weeks of monocular deprivation and one week of recovery. Numbers in parentheses on the x-axis are
the locations of the cytosine-phosphate-guanine (CpG) sites. Methylation at site 11 was significantly less in the monocular deprivation–
recovery (MD-R) eyes than in the NC58 eyes. MD-R: after 7 days of recovery following 4 weeks of monocular deprivation, MD-RC:
contralateral control eyes, NC58: age-matched normal control eyes for MD recovery, *, p<0.05.
Figure  6.  Scleral  collagen  type  Iα1
mRNA levels in monocular deprivation
and  normal  control  eyes.  There  was
significantly  less  collagen  type  Iα1
(COL1A1)    mRNA     in          scleras
from  monocular  deprivation–treated
(MD-T)  eyes  compared  to  the  MD-
control  (MD-C)  eyes  and  the  normal
control  (NC51)  eyes.  MD-C:
contralateral  control  eyes,  NC51:  age-
matched normal control eyes. *, p<0.05.
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1321moderate  myopia.  Thus,  epigenetic  changes  such  as  CpG
methylation of COL1A1 may play a more meaningful role in
low and moderate myopia.
In summary, the frequency of methylation in CpG islands
of the COL1A1 promoter increased in the scleras of mouse
MD eyes compared to control eyes. Associated with this DNA
methylation, transcription of scleral COL1A1 was suppressed.
In  eyes  allowed  to  recover  from  MD,  CpG  methylation
decreased  and  returned  to  a  normal  level,  while  the
transcription of COL1A1 increased. This finding suggests that
DNA methylation of the COL1A1 promoter/exon 1 may be
linked with the inhibition of scleral collagen synthesis, which
contributes to the development of myopia.
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